CCR5 and Huntington disease: Inversely, when we blocked IL-10 and CSF-1 in the WB culture of CD cells with specific anti-IL-10 or CSF-1 inhibitor (GW2580), the percentage of CCR5+ monocytes diminished without reaching HD levels.